Salute e Benessere

PFAS Testing Market worth US$969.5 million by 2030 with 14.5% CAGR |…

Browse in-depth TOC on "PFAS Testing Market" Browse in-depth TOC on "PFAS Testing Market" 200 - Tables50 - Figures400 - Pages By Based on product type,the PFAS testing market is segmented into instruments (liquid chromatography mass spectrometry (Lc-ms), gas chromatography-mass spectrometry (gc-ms), standalone mass spectrometry, nuclear magnetic resonance spectroscopy, other technologies), consumables spe coloumns and cartridges, chromatography columns, reference...
PR Newswire
05/03/2025

CQ Medical's Iris AirShuttle™ Patient Transfer Platform Recognized at Women in…

The Iris AirShuttle is an integral part of CQ Medical's Symphony® Imaging, Treatment & Transfer Solutions, which conveniently integrates the AirShuttle patient platform with the AirDrive™ system. This combination enables smooth and efficient patient transfers between imaging modalities and procedural platforms without the need for repositioning. Designed for use in CT, MR (up to 3 Tesla), and angiography, the Symphony solution ensures safe patient movement across various surfaces, including…
PR Newswire
05/03/2025

BTL's EMFACE Surpasses 1 Million Treatments, Becoming the Fastest-Growing…

"The ability to stimulate elevator muscles allows us to lift facial features from within—something that was never possible before with injectables or traditional energy-based devices," said Dr. Yael Halaas, a facial plastic surgeon from NYC, USA. "The ability to stimulate elevator muscles allows us to lift facial features from within—something that was never possible before with injectables or traditional energy-based devices,"said Dr.Yael Halaas, a facial plastic surgeon…
PR Newswire
05/03/2025

KFSHRC Rises 20 Spots in Newsweek's Global Top 250 Hospitals Ranking

Recognized as Saudi Arabia's Leading Hospital for the Fourth Consecutive Year RIYADH, Saudi Arabia, March05, 2025(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has again secured its position as the top hospital in Saudi Arabia for the fourth consecutive year, according to Newsweek's 2025 ranking of the world's best hospitals. KFSHRC has made strides, jumping 20 places from last year's list, indicating a 9% improvement in this prestigious ranking...
Nasdaq GlobeNewswire
05/03/2025

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.Please see attached the full announcement. Attachment 2025_07_Trading_By_Management
Nasdaq GlobeNewswire
05/03/2025

ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT FEBRUARY 2025

Accumulated revenue for January – February 2025 increased by 53% to SEK 450.8 (295.0) million. Accumulated revenue for January –February 2025increased by 53% toSEK 450.8(295.0) million. Revenues were distributed as follows: Countries in regions:-The Nordics:Denmark, Faroe Island,Finland,Iceland,Norway,Sweden- Central Europe :Austria,Germany,Switzerland- East Europe :Czech Republic,Slovakia,Hungary,Poland,Romania-South &West Europe...
PR Newswire
05/03/2025

Initiation of share buyback program

The shares acquired in the program will be used to meet obligations arising from employee share-based incentive programs.The maximum number of shares to be purchased by the company per daily market session will be equivalent to no more than 25% of the average volume of shares in the company traded on NASDAQ OMX Copenhagen during the preceding 20 business days. The program will run in accordance with the European Commission Regulation (EU) No. 596/2014 of 16 April 2014 (the "Market Abuse...
Nasdaq GlobeNewswire
05/03/2025

Report of transactions of shares and related securities of Bavarian Nordic by…

COPENHAGEN, Denmark, March 5, 2025– Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company's shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such, which are hereby reported in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523.The transactions relate to the award and vesting of restricted stock units...
Nasdaq GlobeNewswire
05/03/2025

Orion and Aiforia extend collaboration to preclinical study evaluations

ORION CORPORATIONPRESS RELEASE5 MARCH 2025 at 9.00 EET Orion and Aiforia extend collaboration to preclinical study evaluations Orion Corporation (“Orion”) and Aiforia Technologies Plc (“Aiforia”), a Finnish medical software company, today announced the extension of their collaboration to include the use of Aiforia's software solution for preclinical study evaluations. This collaboration will involve implementing the Aiforia ® Studies module within Orion's preclinical...
Nasdaq GlobeNewswire
05/03/2025

Bavarian Nordic Publishes Annual Report 2024

Audited results confirm full-year revenue of DKK 5,716 million and EBITDA of DKK 1,603 million.Two new early-stage pipeline programs, Lyme disease and Epstein-Barr Virus (EBV), introduced.COPENHAGEN, Denmark, March 5, 2025– Bavarian Nordic A/S (OMX: BAVA) today published its Annual Report for 2024. The consolidated, audited results were in line with the preliminary results announced on February 3, 2025. The full report is attached as a PDF file and can be found on the Company's...
Nasdaq GlobeNewswire
05/03/2025

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities…

ORION CORPORATIONSTOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 5 March 2025 at 8.30 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds decreased on 3 March 2025 below...
Nasdaq GlobeNewswire
05/03/2025

FDA accepts supplemental Biologics License Application for Roche's…

Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody in a randomised phase III study to demonstrate a complete renal response benefit 1 The filing application is based on data from the phase III REGENCY study, where Gazyva/Gazyvaro showed superiority over standard therapy alone in people with active lupus nephritis 1 Lupus nephritis affects 1.7 million people worldwide; up to one-third of people on current treatments will progress to end-stage kidney disease within 10...
Nasdaq GlobeNewswire
05/03/2025

Sandoz reports strong FY 2024 results and Q4 2024 sales

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASEFY 2024 net sales[1] of USD 10.4 billion, up by 9%[2] in constant currencies (+7% in USD); Q4 net sales of USD 2.7 billion, up by 9% in constant currencies (+7% in USD)Strong sales performances in all three regions, driven by double-digit growth in biosimilars, both in the fourth quarter and full year, benefitting from recent launches and base-business momentumOperating income of USD 307 million, up...
Nasdaq GlobeNewswire
05/03/2025

CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield…

The decision to locate the plant near Basel is supported by several key advantages, including: The decision to locate the plant nearBaselis supported by several key advantages, including: This >€500 million investment will feature multiple manufacturing lines capable of supporting small, medium, and large-scale peptide production with small- to large-scale Solid Phase Peptide Synthesis (SPPS) reactors for GLP-1 and non-GLP-1 peptide projects – with a total SPPS reactor capacity of...
PR Newswire
05/03/2025

Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market…

Among the 7MM, the United States had the highest prevalence of tenosynovial giant cell tumor, accounting for approximately 45% of total cases. In 2023, localized TGCT in the U.S. was most commonly found in the digits, representing around 75% of cases. Depending on whether the tumor is localized or diffuse, giant cell tumors can also occur in the knee, ankle, hip, and other areas. According to DelveInsight analysts, diffuse TGCT was most frequently observed in the knee, with an estimated 30,000…
PR Newswire
04/03/2025

Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market…

Among the 7MM, the United States had the highest prevalence of tenosynovial giant cell tumor, accounting for approximately 45% of total cases. In 2023, localized TGCT in the U.S. was most commonly found in the digits, representing around 75% of cases. Depending on whether the tumor is localized or diffuse, giant cell tumors can also occur in the knee, ankle, hip, and other areas. According to DelveInsight analysts, diffuse TGCT was most frequently observed in the knee, with an estimated 30,000…
PR Newswire
04/03/2025

Coming change of the Chair of the Board of Directors

CHAIR KENT ARENTOFT STEPS DOWN AFTER 12 YEARS OF LEADERSHIP CHAIR KENT ARENTOFT STEPS DOWN AFTER 12 YEARS OF LEADERSHIP ChairKent Arentofthas informed the Board of Directors that he will step down at the coming annual general meeting on8 April 2025and leave the Board of Directors.Kent Arentofthas acted as Chair sinceApril 2013when he was first elected as board member. Under his guidance, H+H has experienced significant growth, consolidating the Polish AAC market,...
PR Newswire
04/03/2025

Mesotherapy Market Size Expected to Reach US$ 1,148.60 Million by 2030, Growing…

Global mesotherapy market is recording significant growth. Key factors driving growth of the market include the increasing adoption of mesotherapy for various therapeutic purposes and the surging use of the therapy in combination with platelet-rich plasma (PRP) therapy. The report runs an in-depth analysis of market trends, key players, and future opportunities. Global mesotherapy market is recording significant growth. Key factors driving growth of the market include the increasing adoption…
PR Newswire
04/03/2025

Hyperpigmentation Disorder Treatment Market Size to Reach US$ 11.78Billion by…

The hyperpigmentation disorder treatment market is experiencing significant growth. Factors such as simplified and minimally invasive procedures; a wide range of applications; and improvements in comfort, efficiency, and outcomes with technological advancements propel the hyperpigmentation disorder treatment market. However, the potential side effects and regulatory challenges hamper the growth of the market. The growing adoption of novel products based on path-3 technology is further expected…
PR Newswire
04/03/2025

Transactions with shares and linked securities in Genmab A/S made by managerial…

Company Announcement COPENHAGEN, Denmark; March 4, 2025 –Genmab A/S(Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons.The company's managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish...
Nasdaq GlobeNewswire
04/03/2025

Medical Refrigerators Market Size Set for Tremendous Growth, Projected to Reach…

To explore the valuable insights in the Medical Refrigerators Market report, you can easily download a sample PDF of the report- https://www.theinsightpartners.com/sample/TIPRE00006857/ To explore the valuable insights in the Medical Refrigerators Market report, you can easily download a sample PDF of the report- https://www.theinsightpartners.com/sample/TIPRE00006857/ The report runs an in-depth analysis of market trends, key players, and future opportunities. The medical...
PR Newswire
04/03/2025

AI in Remote Patient Monitoring (RPM) Market worth $8,438.5 million by 2030 with…

Browse in-depth TOC on 'Artificial Intelligence in Remote Patient Monitoring Market' Browse in-depth TOC on 'Artificial Intelligence in Remote Patient Monitoring Market' 290 - Tables 59 - Figures 323 - Pages By component,the artificial intelligence in remote patient monitoring market has been segmented into devices, software and services. In 2023, devices segment is estimated to hold the largest share of the market for AI in remote patient monitoring. AI-powered wearables...
PR Newswire
04/03/2025

Photoacoustic Imaging Market is expected to generate a revenue of USD 133.72…

As medical imaging continues to evolve, photoacoustic imaging (PAI) is emerging as a transformative technology, providing high-resolution, real-time imaging with deeper tissue penetration. As medical imaging continues to evolve, photoacoustic imaging (PAI) is emerging as a transformative technology, providing high-resolution, real-time imaging with deeper tissue penetration. Key Highlights of the Market Report : With increasing applications in oncology, dermatology, cardiology, and...
PR Newswire
04/03/2025

Digital Denture Market is expected to generate a revenue of USD 2.82 Billion by…

The report delivers a comprehensive analysis of market trends, growth drivers, technological advancements, and competitive dynamics shaping the digital denture landscape. With the increasing adoption of CAD/CAM technology, 3D printing, and AI-driven design solutions, the market is witnessing a shift toward faster, more precise, and cost-effective denture production. The report delivers a comprehensive analysis of market trends, growth drivers, technological advancements, and competitive...
PR Newswire
04/03/2025
Altri  Comunicati